Big Pharma Has to Bet Big on M&A. Investors Don’t.

(Bloomberg Opinion) -- AbbVie Inc.’s  $63 billion purchase of Botox maker Allergan Inc. is the third super-sized drug deal announced in the past 14 months, and the second just this year after Brist...

Bloomberg Quint

Add BloombergQuint App to Home screen.